An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This research is being done to find out if pemetrexed and cisplatin work better when given
together with an experimental drug called MORAb-009 in patients with malignant pleural
mesothelioma.